Tissue Regenix Group

Summary by AI ^BETAClose X

FTSE Russell has announced the deletion of Tissue Regenix Group from its indices, effective for the open on December 22, 2025, at a nominal value of 0.0001. This decision follows a 40-business day suspension without indication of resumption, as per the Suspension of Dealing rule. This action impacts the FTSE AIM All-Share Index and signifies a significant event for the company's market presence.

Disclaimer*

FTSE Russell

17 December 2025

Suspended Company Notice - Deletion

17 December 2025

Further to the notice released on 19 November 2025, the following company has been suspended 40 business days without indication of resumption. In accordance with the Suspension of Dealing rule, it will be removed from the FTSE Russell Index for the open of 22 December 2025 at nominal value (0.0001).

· Tissue Regenix Group (BNTXR10, FTSE AIM All-Share Index)

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia	+61 (0) 2 7228 5659
Hong Kong	+852 2164 3333
Japan	+81 3 6441 1430
London	+44 (0) 20 7866 1810
New York	+1877 503 6437

Alternatively, please visit our website at lseg.com/ftse-russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END